FASN and infection: To test whether FASN inhibition has an antiviral effect in vivo, we infected BALB/c mice with RSV A (Long) by intranasal inoculation, and orally administered 50 mg/kg TVB-3166 twice a day, starting either on the day of infection or one day post infection (Fig 7A).